Tracking the pre-clinical progression of transthyretin amyloid cardiomyopathy using artificial intelligence-enabled electrocardiography and echocardiography.
Evangelos K OikonomouVeer SanghaSumukh Vasisht ShankarAndreas CoppiHarlan M KrumholzKhurram NasirRobert J H MillerCesia Gallegos-KattanSadeer Al-KindiRohan KheraPublished in: medRxiv : the preprint server for health sciences (2024)
AI applied directly to echocardiography and ECG images may define a scalable paradigm in the monitoring of pre-clinical ATTR-CM progression and identify candidates who may benefit from initiation of disease-modifying therapies.